---
title: "CASI Pharmaceuticals (CASI.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CASI.US/norm.md"
symbol: "CASI.US"
name: "CASI Pharmaceuticals"
parent: "https://longbridge.com/en/quote/CASI.US.md"
datetime: "2026-03-12T12:27:22.838Z"
locales:
  - [en](https://longbridge.com/en/quote/CASI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CASI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CASI.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CASI.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CASI.US/norm.md)


# CASI Pharmaceuticals (CASI.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.6781 | -0.8626 | -0.6939 | -0.7510 | -0.5489 |
| ROE | 178.04% | 377.03% | 1382.86% | -732.32% | -293.69% |
| Revenue | 3.08M | 4.17M | 6.24M | 13.36M | 7.79M |
| Net income | -10.88M | -13.38M | -10.75M | -14.37M | -8.39M |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 24.46M | 31.20M | 40.82M | 53.67M | 63.62M |
| Leverage | -0.8556 | -1.54 | -5.06 | 29.00 | 4.59 |
| BVPS | -1.39 | -1.31 | -0.5209 | 0.1195 | 0.9054 |
| Turnover | 0.6096 | 0.7654 | 0.6348 | 0.4426 | 0.3200 |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | - | - | - | - |
| Investing CF | - | - | - | - | - |
| Financing CF | - | - | - | - | - |
| Free CF | - | - | - | - | - |